The #CRESENT trial is working to innovate the way we treat #ObstructiveSleepApnea (OSA); the current most common treatment is the #CPAP. Here, 220 participants aged 40+ compare quality of life using the #CPAP versus #mandibularadvancement for #sleepapneatreatment.
academic.oup.com/sleep/articl...
4
1
0
1